Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
Jennifer G. Robinson
Based on 28 articles published since 2008
||||
Expertise Level
The expertise of Jennifer G. Robinson ranks in the
  • Top 0.0035%
  • ... of 28,550 published authors worldwide on Hypercholesterolemia
  • ... from 2008 through 2018
  • ... based on contributions to 28 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Robinson, Jennifer G   ·   Robinson, Jennifer
Work Locations
Details
Most likely:    University of Iowa   Contact    
2017
  • Lipid Clinic, Point Médical, Dijon, France; Department of Cardiology, CHU Dijon Bourgogne, Dijon, France. Electronic address: · University of Edinburgh, Edinburgh, UK. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Sanofi, Bridgewater, NJ, USA. · Sanofi, Chilly-Mazarin, France. · University of Iowa, Iowa City, IA, USA. · Pubmed 28693998
  • Department of Medicine, ECOGENE-21 Clinical and Translational Research Center and Lipidology Unit, Université de Montréal, Chicoutimi, Quebec, Canada. Electronic address: · Lipid Disorders Clinic, Centre for Cardiovascular Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia. · University of Iowa, Iowa City, Iowa. · Biostatistics and Programming, Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · Sanofi, Bridgewater, New Jersey. · Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa. · Pubmed 27793396
  • University of Iowa, Iowa City, Iowa. Electronic address: · Icahn School of Medicine at Mount Sinai, New York, New York. · Point Médical, Dijon, France. · Sanofi, Bridgewater, New Jersey. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc., Basking Ridge, New Jersey. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands. · Pubmed 28153102
2016
  • Departments of Epidemiology & Medicine, Colleges of Public Health & Medicine, University of Iowa, Iowa City, Iowa. Electronic address: · Pubmed 27498088
  • University of Edinburgh, Edinburgh, UK · Columbia University, New York, NY, USA. · University of Iowa, Iowa City, IA, USA. · Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. · University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen University, Aachen, Germany. · University of California San Diego School of Medicine, La Jolla, CA, USA. · Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, CA, USA. · CHU Nantes, Institut du Thorax, France. · Sanofi, Montpellier, France. · Regeneron Pharmaceuticals, Tarrytown, NY, USA. · Sanofi, Paris, France. · University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. · Pubmed 27460890
  • Baylor College of Medicine, Houston, Texas. Electronic address: · Louisville Metabolic and Atherosclerosis Research Center (L-MARC), Louisville, Kentucky. · Sanofi, Bridgewater, New Jersey. · Regeneron, Tarrytown, New York. · Sanofi, Chilly-Mazarin, France. · Regeneron, Basking Ridge, New Jersey. · University of Iowa, Iowa City, Iowa. · Pubmed 27729106
2015
  • From the Department of Medicine, Robarts Research Institute, Schulich School of Medicine, Western University, London, Ontario, Canada (R.A.H.) · Nemours Cardiac Center, A. I. duPont Hospital for Children, Wilmington, DE (S.S.G.) · Irving Institute for Clinical and Translational Research, Department of Medicine, Columbia University, New York, NY (H.N.G.) · Department of Medicine and Biochemistry, Atherogenomics Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada (R.M.) · Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa (F.J.R) · Department of Genetics (D.J.R.) and Division of Translational Medicine and Human Genetics, Department of Medicine (D.J.R.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia · Department of Epidemiology and Medicine, University of Iowa, Iowa City (J.G.R.) · and Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (F.K.W.). · Pubmed 26376908
  • University of Iowa, Iowa City, IA, USA. · University of Iowa, Iowa City, IA, USA. Electronic address: · Pubmed 25936907
  • aDepartment of Epidemiology bDepartment of Medicine cPrevention Intervention Center, University of Iowa, Iowa City, Iowa, USA. · Pubmed 25887679
  • The Christ Hospital, Heart and Vascular Center/The Lindner Research Center, Cincinnati, OH. Electronic address: · University of Iowa, Iowa City, IA. · Harvard Clinical Research Institute, Boston, MA. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc, Tarrytown, NY. · Sanofi, Bridgewater, NJ. · University of Dundee, Dundee, Scotland, United Kingdom. · Pubmed 26027630
  • From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and the Department of Medicine, Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W.) · the Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg (F.J.R.), and the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town (D.J.B.) - both in South Africa · the Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa City (J.R.) · the Sections of Cardiovascular Research and Cardiology, Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.) · Amgen, Thousand Oaks, CA (R. Somaratne, J.L., S.M.W., R. Scott) · Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.) · and the Metabolic and Atherosclerosis Research Center, Cincinnati (E.A.S.). · Pubmed 25773607
  • From the University of Iowa, Iowa City (J.G.R.) · Point Médical, Dijon (M.F.), Centre Hospitalier Universitaire de Nantes-Hôpital Nord Laennec, Saint-Herblain (M.K.), University Hospital of Lille, Lille (G. Luc), and Sanofi, Chilly-Mazarin (C.L.) - all in France · Clinique des Maladies Lipidiques de Québec, Quebec, QC, Canada (J.B.) · Università di Palermo-Policlinico P. Giaccone, Palermo, Italy (M.A.) · the Department of Vascular Medicine, Academic Medical Center, Amsterdam (E.S.S., J.J.P.K.) · Lipid Clinic, Oslo University Hospital, Oslo (G. Langslet) · University of the Witwatersrand, Johannesburg (F.J.R.) · Cardiovascular Center of Sarasota, Sarasota (M.E.S.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida · Westside Medical Associates of Los Angeles, Beverly Hills, CA (N.E.L.) · Regeneron Pharmaceuticals, Tarrytown, NY (R.P.) · and Sanofi, Bridgewater, NJ (U.C.). · Pubmed 25773378
2014
  • Departments of Epidemiology and Medicine and the Prevention Intervention Center, Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA. Electronic address: · Pubmed 25131695
  • Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa City, Iowa. · Pubmed 25269777
  • The Sterling Research Group, Cincinnati, OH, USA. Electronic address: · Cardiovascular Research Unit, Diabetes and Obesity Research Program, University of Helsinki, Finland. · Columbia University, New York, NY, USA. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. · Medical Research Institute, University of Dundee, Dundee, UK. · College of Public Health, University of Iowa, IA, USA. · Sanofi, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Sanofi, Montpellier, France. · Pubmed 25037695
  • Department of Epidemiology, College of Public Health, University of Iowa, Iowa City2Department of Medicine, College of Public Health, University of Iowa, Iowa City. · Center for Clinical and Basic Research, Aalborg, Denmark. · Division of Cardiovascular Disease, University of Alabama Medical Center, Birmingham. · Department of Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami. · Orange County Research Center, Tustin, California. · Hampton Roads Center for Clinical Research, Suffolk, Virginia. · Amgen Inc, Thousand Oaks, California. · Maine Research Associates, Auburn. · Pubmed 24825642
  • Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa, Iowa. · Pubmed 24481874
2011
  • Departments of Epidemiology & Medicine, University of Iowa College of Public Health, Iowa City, IA 52242, USA. · Pubmed 22108151
2009
  • University of Iowa College of Public Health, Iowa City, Iowa, USA. · Pubmed 19539078
2014
  • *College of Pharmacy †College of Public Health, University of Iowa, Iowa City, IA. · Pubmed 24561757
Possible:    University of Chester      
2014
Possible:    University of Dundee      
2014
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 28 total) written by Jennifer G. Robinson about Hypercholesterolemia:

  • Long-term treatment adherence to the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab in 6 ODYSSEY Phase III clinical studies with treatment duration of 1 to 2 years. 2017
  • Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program). 2017
  • Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab: Pooled Data From Randomized Trials. 2017
  • Nonstatins and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors: Role in Non-Familial Hypercholesterolemia. 2016
  • No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY Phase 3 studies. 2016
  • Safety of Alirocumab (A PCSK9 Monoclonal Antibody) from 14 Randomized Trials. 2016
  • Nonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB Council. 2015
  • Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition and the Future of Lipid Lowering Therapy. 2015
  • Statins and diabetes risk: how real is it and what are the mechanisms? 2015
  • Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study. 2015
Show List of Full Article Records
Google Searches

Learn more about Jennifer G. Robinson using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Iowa
University of Chester
University of Dundee
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Iowa
2017
  • Lipid Clinic, Point Médical, Dijon, France; Department of Cardiology, CHU Dijon Bourgogne, Dijon, France. Electronic address: · University of Edinburgh, Edinburgh, UK. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Sanofi, Bridgewater, NJ, USA. · Sanofi, Chilly-Mazarin, France. · University of Iowa, Iowa City, IA, USA. · Pubmed 28693998
  • Department of Medicine, ECOGENE-21 Clinical and Translational Research Center and Lipidology Unit, Université de Montréal, Chicoutimi, Quebec, Canada. Electronic address: · Lipid Disorders Clinic, Centre for Cardiovascular Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia. · University of Iowa, Iowa City, Iowa. · Biostatistics and Programming, Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · Sanofi, Bridgewater, New Jersey. · Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa. · Pubmed 27793396
  • University of Iowa, Iowa City, Iowa. Electronic address: · Icahn School of Medicine at Mount Sinai, New York, New York. · Point Médical, Dijon, France. · Sanofi, Bridgewater, New Jersey. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc., Basking Ridge, New Jersey. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands. · Pubmed 28153102
2016
  • Departments of Epidemiology & Medicine, Colleges of Public Health & Medicine, University of Iowa, Iowa City, Iowa. Electronic address: · Pubmed 27498088
  • University of Edinburgh, Edinburgh, UK · Columbia University, New York, NY, USA. · University of Iowa, Iowa City, IA, USA. · Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. · University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen University, Aachen, Germany. · University of California San Diego School of Medicine, La Jolla, CA, USA. · Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, CA, USA. · CHU Nantes, Institut du Thorax, France. · Sanofi, Montpellier, France. · Regeneron Pharmaceuticals, Tarrytown, NY, USA. · Sanofi, Paris, France. · University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. · Pubmed 27460890
  • Baylor College of Medicine, Houston, Texas. Electronic address: · Louisville Metabolic and Atherosclerosis Research Center (L-MARC), Louisville, Kentucky. · Sanofi, Bridgewater, New Jersey. · Regeneron, Tarrytown, New York. · Sanofi, Chilly-Mazarin, France. · Regeneron, Basking Ridge, New Jersey. · University of Iowa, Iowa City, Iowa. · Pubmed 27729106
2015
  • From the Department of Medicine, Robarts Research Institute, Schulich School of Medicine, Western University, London, Ontario, Canada (R.A.H.) · Nemours Cardiac Center, A. I. duPont Hospital for Children, Wilmington, DE (S.S.G.) · Irving Institute for Clinical and Translational Research, Department of Medicine, Columbia University, New York, NY (H.N.G.) · Department of Medicine and Biochemistry, Atherogenomics Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada (R.M.) · Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa (F.J.R) · Department of Genetics (D.J.R.) and Division of Translational Medicine and Human Genetics, Department of Medicine (D.J.R.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia · Department of Epidemiology and Medicine, University of Iowa, Iowa City (J.G.R.) · and Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (F.K.W.). · Pubmed 26376908
  • University of Iowa, Iowa City, IA, USA. · University of Iowa, Iowa City, IA, USA. Electronic address: · Pubmed 25936907
  • aDepartment of Epidemiology bDepartment of Medicine cPrevention Intervention Center, University of Iowa, Iowa City, Iowa, USA. · Pubmed 25887679
  • The Christ Hospital, Heart and Vascular Center/The Lindner Research Center, Cincinnati, OH. Electronic address: · University of Iowa, Iowa City, IA. · Harvard Clinical Research Institute, Boston, MA. · Sanofi, Chilly-Mazarin, France. · Regeneron Pharmaceuticals, Inc, Tarrytown, NY. · Sanofi, Bridgewater, NJ. · University of Dundee, Dundee, Scotland, United Kingdom. · Pubmed 26027630
  • From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and the Department of Medicine, Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W.) · the Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg (F.J.R.), and the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town (D.J.B.) - both in South Africa · the Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa City (J.R.) · the Sections of Cardiovascular Research and Cardiology, Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.) · Amgen, Thousand Oaks, CA (R. Somaratne, J.L., S.M.W., R. Scott) · Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.) · and the Metabolic and Atherosclerosis Research Center, Cincinnati (E.A.S.). · Pubmed 25773607
  • From the University of Iowa, Iowa City (J.G.R.) · Point Médical, Dijon (M.F.), Centre Hospitalier Universitaire de Nantes-Hôpital Nord Laennec, Saint-Herblain (M.K.), University Hospital of Lille, Lille (G. Luc), and Sanofi, Chilly-Mazarin (C.L.) - all in France · Clinique des Maladies Lipidiques de Québec, Quebec, QC, Canada (J.B.) · Università di Palermo-Policlinico P. Giaccone, Palermo, Italy (M.A.) · the Department of Vascular Medicine, Academic Medical Center, Amsterdam (E.S.S., J.J.P.K.) · Lipid Clinic, Oslo University Hospital, Oslo (G. Langslet) · University of the Witwatersrand, Johannesburg (F.J.R.) · Cardiovascular Center of Sarasota, Sarasota (M.E.S.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida · Westside Medical Associates of Los Angeles, Beverly Hills, CA (N.E.L.) · Regeneron Pharmaceuticals, Tarrytown, NY (R.P.) · and Sanofi, Bridgewater, NJ (U.C.). · Pubmed 25773378
2014
  • Departments of Epidemiology and Medicine and the Prevention Intervention Center, Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA. Electronic address: · Pubmed 25131695
  • Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa City, Iowa. · Pubmed 25269777
  • The Sterling Research Group, Cincinnati, OH, USA. Electronic address: · Cardiovascular Research Unit, Diabetes and Obesity Research Program, University of Helsinki, Finland. · Columbia University, New York, NY, USA. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. · Medical Research Institute, University of Dundee, Dundee, UK. · College of Public Health, University of Iowa, IA, USA. · Sanofi, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. · Sanofi, Montpellier, France. · Pubmed 25037695
  • Department of Epidemiology, College of Public Health, University of Iowa, Iowa City2Department of Medicine, College of Public Health, University of Iowa, Iowa City. · Center for Clinical and Basic Research, Aalborg, Denmark. · Division of Cardiovascular Disease, University of Alabama Medical Center, Birmingham. · Department of Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami. · Orange County Research Center, Tustin, California. · Hampton Roads Center for Clinical Research, Suffolk, Virginia. · Amgen Inc, Thousand Oaks, California. · Maine Research Associates, Auburn. · Pubmed 24825642
  • Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa, Iowa. · Pubmed 24481874
2011
  • Departments of Epidemiology & Medicine, University of Iowa College of Public Health, Iowa City, IA 52242, USA. · Pubmed 22108151
2009
  • University of Iowa College of Public Health, Iowa City, Iowa, USA. · Pubmed 19539078
2014
  • *College of Pharmacy †College of Public Health, University of Iowa, Iowa City, IA. · Pubmed 24561757
University of Chester
2014
University of Dundee
2014
Yearly article counts 033711001111
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.